The Medicines Company Reports Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Medicines Co. (MDCO) Reports Q2 Loss of $0.63/Share
August 1, 2018 7:09 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($0.63), versus ($0.72) reported last year. Revenue for the quarter came in at $1.67 million, versus $10.86 million reported last year.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More